about
Nicotine vaccines for smoking cessationNicotine vaccines for smoking cessationPeer smoking and the nicotinic receptor genes: an examination of genetic and environmental risks for nicotine dependenceHigh levels of tobacco-specific N-nitrosamines and nicotine in Chaini Khaini, a product marketed as snusNovel genes identified in a high-density genome wide association study for nicotine dependenceDevelopmental toxicity of nicotine: A transdisciplinary synthesis and implications for emerging tobacco products.Women and Smoking: The Effect of Gender on the Epidemiology, Health Effects, and Cessation of Smoking.Smoking- and menstrual-related symptomatology during short-term smoking abstinence by menstrual phase and depressive symptomsMeasures for assessing subjective effects of potential reduced-exposure products.A genome-wide association study of alcohol dependence.The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans.Applying tobacco carcinogen and toxicant biomarkers in product regulation and cancer prevention.New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels.A pilot study of concurrent lead and cotinine screening for childhood tobacco smoke exposure: effect on parental smoking.Chronic disease management for tobacco dependence: a randomized, controlled trialPublic education about the relative harm of tobacco products: an intervention for tobacco control professionalsTime to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence.Interplay of Genetic Risk Factors and Parent Monitoring in Risk for Nicotine Dependence.Beyond cigarettes per day. A genome-wide association study of the biomarker carbon monoxide.Efficacy of naltrexone in smoking cessation: a preliminary study and an examination of sex differences.Immediate consequences of cigarette smoking: rapid formation of polycyclic aromatic hydrocarbon diol epoxidesSubjective response to nicotine by menstrual phase.Presence of the carcinogen N'-nitrosonornicotine in the urine of some users of oral nicotine replacement therapy productsThe effect of combination oral contraceptives on smoking-related symptomatology during short-term smoking abstinence.Effects of nicotine patch or nasal spray on nicotine and cotinine concentrations in pregnant smokersInclusion of African Americans in genetic studies: what is the barrier?Elevated levels of 1-hydroxypyrene and N'-nitrosonornicotine in smokers with head and neck cancer: A matched control study.Rare missense variants in CHRNB4 are associated with reduced risk of nicotine dependence.The blind spot in the nicotine replacement therapy literature: assessment of the double-blind in clinical trials.Sex differences in hormonal responses to stress and smoking relapse: a prospective examination.Dissection of the phenotypic and genotypic associations with nicotinic dependence.Menstrual phase effects on smoking relapse.Genetic variation (CHRNA5), medication (combination nicotine replacement therapy vs. varenicline), and smoking cessation.Nicotine dependence and comorbid psychiatric disorders: examination of specific genetic variants in the CHRNA5-A3-B4 nicotinic receptor genes.Menstrual phase, depressive symptoms, and allopregnanolone during short-term smoking cessation.Effects of high dose transdermal nicotine replacement in cigarette smokersAssessing Constituent Levels in Smokeless Tobacco Products: A New Approach to Engaging and Educating the Public.Increased genetic vulnerability to smoking at CHRNA5 in early-onset smokers.Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs.Menstrual phase and depressive symptoms differences in physiological response to nicotine following acute smoking abstinence.
P50
Q24201422-A4279E27-2DAA-4AD7-9855-FD8D23ABDE55Q24243661-094B1907-60CD-4AF9-94FE-B61B2F20550EQ28315283-8E26F26C-1F3B-4E8F-AE78-520AB2ED068AQ28831487-81B89CBE-DFCD-432F-A719-95ADE0F4FAA0Q28943515-12562D48-AD31-4352-97B5-F6C68AD1B270Q30240579-C6A102B2-1C63-42FD-9EB1-575F2583BCBCQ30383572-3DFFD5CD-BF7E-4538-8847-44DBE9390AF0Q33566909-834FA155-1106-463B-9940-64B2C52E9008Q33649339-7E59D111-C0C1-4529-A33B-D7B2E29A762CQ33740277-6DF285CF-90BB-4122-874E-A05F6FCC1195Q33868026-3013D476-AAA0-4D51-A233-AC9FB369501BQ33936367-8AE57740-1C41-466D-A4D7-AF9CB9654EB1Q33943746-F61E5C0F-DF72-470E-9924-4127D3975FBFQ33949631-C76CD5AA-5224-46EE-AAC4-E012FB04725FQ33949648-DA160ACA-DB15-493B-8CDE-B2E505448132Q33990091-8EF7F847-053F-4047-92BB-4EFB61AE09F0Q34105568-32039E3E-5D82-4415-8BED-1C126DE57CB2Q34146547-FDF358B3-04C0-4A2F-9033-32D44981FC9CQ34425646-E6CC2E79-A93F-44ED-AE5E-CE166C05BB3BQ34569751-6313A65F-0E72-4908-A5D5-16D7655C2CD5Q34587726-BB32E782-E381-4005-8658-730BFE5E6BBDQ35007625-4899EB98-4C8F-448B-BA79-3151300D11D1Q35008757-7BF2295A-D4F3-4540-B809-2E153F3A18ADQ35040284-0000828B-A563-4076-BF61-A8BD5A353505Q35205504-C3090695-7280-402D-A435-65F33FBA04FCQ35450602-CEB0836E-AA52-4B61-A44C-BD5796476D4FQ35566185-65E6BE34-276A-44B2-AF60-E8BDDF0ADB9DQ35674705-4B2827A7-AB86-4434-B7F8-B319BA2A4D72Q35769427-FFFA3271-75F1-434C-A5C6-B6599CD806BDQ35784980-427C5AF6-72B6-444F-B7E2-85EADF7CB83DQ35856206-E6E30E48-9773-4340-BF81-BC75206EEB74Q35900455-0DC85600-0966-4C51-BB1C-0968D11B45C6Q35956179-2DDCD58F-2E90-49FA-AA6D-83B6AEECAC8CQ36037208-434F3B12-E6D6-4162-ACC7-EF91DEA3C2C9Q36071761-E37263B0-62C8-40A6-9EE9-74C7E415E02BQ36116552-F410941F-9773-4069-B7D3-BBDC2093C46CQ36181359-FF6F7F5C-451D-44E3-A0DD-159C2CBDA623Q36350246-9B71CDED-1914-4A98-97DC-FF9144E7D44FQ36501908-08ACE54C-EC81-423F-AD25-070E54E7C030Q36823237-D018994B-9A53-4829-BF7C-6564D5E4FEEF
P50
name
Dorothy Hatsukami
@en
type
label
Dorothy Hatsukami
@en
prefLabel
Dorothy Hatsukami
@en